We use cookies to personalize content, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. For information on how to change your cookie settings, please see our Privacy policy. Otherwise, if you agree to our use of cookies, please continue to use our website.

Chris Colella

Senior Director, Business Development, Health
Chris Collela

Chris has more than 15 years of experience in driving significant market presence while balancing return on investment for leading brands such as AstraZeneca, Eli Lilly, Glaxo Smith Kline, Johnson & Johnson, Novartis and Sanofi. Chris’s detailed approach in understanding the client’s business objectives, their competitive landscape, and defining what success means to them has resulted in a track record of driving a significant return on marketing dollar spent for both professional and consumer marketing campaigns.

Prior to joining Merkle, Chris was with Epsilon where he led business development efforts within the Health vertical by developing partnerships with top pharma, biotech, insurance, and medical device companies. Chris has a degree in Business and Marketing from the University of Delaware.

Chris's Articles, Blog Posts, Webinars and More

Personalized Marketing Approach Increased HCP Responses by 32%

When we got the opportunity to speak at the Pharmaceutical Management Science Association (PMSA) conference, we never dreamed that our submission would lead to winning an award. We were so excited to learn that our peers voted our poster as "best poster presentation." This poster showed the impact of a personalized tele-detailing approach where 32% of targeted HCPs requested copays or samples, proving that messaging and offers were relevant and desirable.